Terms: = Lung cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Prognosis
10 results:
1. mecom: a bioinformatics and experimentally identified marker for the diagnosis and prognosis of lung adenocarcinoma.
Li A; Li M; Wang J; Zhou J; Yang T; Fan M; Zhang K; Gao H; Ren H; Chen M
Biomark Med; 2024 Jan; 18(2):79-91. PubMed ID: 38440890
[TBL] [Abstract] [Full Text] [Related]
2. Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patients.
de Boysson H; Cuchet M; Cassius C; Cuchet P; Agard C; Audemard-Verger A; Marchand-Adam S; Cohen-Sors R; Gallay L; Graveleau J; Lesort C; Ly K; Meyer A; Monseau G; Néel A; Bonnotte B; Pérard L; Schleinitz N; Mariotte D; Le Mauff B; Bourdenet G; Masmoudi W; Deshayes S; Dumont A; Dompmartin A; Kottler D; Aouba A
Front Immunol; 2023; 14():1319957. PubMed ID: 38259447
[TBL] [Abstract] [Full Text] [Related]
3. Heat shock protein B7 (HSPB7) inhibits lung adenocarcinoma progression by inhibiting glycolysis.
Chen Z; Li P; Shen L; Jiang X
Oncol Rep; 2023 Nov; 50(5):. PubMed ID: 37732539
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological Features and prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
5. Integrative weighted molecular network construction from transcriptomics and genome wide association data to identify shared genetic biomarkers for COPD and lung cancer.
Banaganapalli B; Mallah B; Alghamdi KS; Albaqami WF; Alshaer DS; Alrayes N; Elango R; Shaik NA
PLoS One; 2022; 17(10):e0274629. PubMed ID: 36194576
[TBL] [Abstract] [Full Text] [Related]
6. CRISPR-mediated mecom depletion retards tumor growth by reducing cancer stem cell properties in lung squamous cell carcinoma.
Ma Y; Kang B; Li S; Xie G; Bi J; Li F; An G; Liu B; Li J; Shen Y; Xu X; Yang H; Yang Y; Gu Y; Wu N
Mol Ther; 2022 Nov; 30(11):3341-3357. PubMed ID: 35733338
[TBL] [Abstract] [Full Text] [Related]
7. evi1 as a Marker for Lymph Node Metastasis in HNSCC.
Idel C; Ribbat-Idel J; Kuppler P; Krupar R; Offermann A; Vogel W; Rades D; Kirfel J; Wollenberg B; Perner S
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013033
[TBL] [Abstract] [Full Text] [Related]
8. Potential Diagnostic and Prognostic Biomarkers of Circular RNAs for lung cancer in China.
Wang C; Jiang Y; Lei Q; Wu Y; Shao J; Pu D; Li W
Biomed Res Int; 2019; 2019():8023541. PubMed ID: 31534962
[TBL] [Abstract] [Full Text] [Related]
9. Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules.
Pelosi G; Pellegrinelli A; Fabbri A; Tamborini E; Perrone F; Settanni G; Busico A; Picciani B; Testi MA; Militti L; Maisonneuve P; Valeri B; Sonzogni A; Proto C; Garassino M; De Braud F; Pastorino U
Virchows Arch; 2016 Jun; 468(6):651-62. PubMed ID: 27056568
[TBL] [Abstract] [Full Text] [Related]
10. Amplification of MDS1/evi1 and evi1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
[TBL] [Abstract] [Full Text] [Related]
